BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37939914)

  • 1. Development of lymph node metastasis-related prognostic markers in breast cancer.
    Pan Y; Zou Q; Yin W; Huang Z; Zhao Y; Mo Z; Li L; Yang J
    J Proteomics; 2024 Jan; 291():105045. PubMed ID: 37939914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
    Wang Z; Liu H; Gong Y; Cheng Y
    Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
    Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
    Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients.
    Wang K; Li H; Zhao J; Yao J; Lu Y; Dong J; Bai J; Liao L
    Front Cell Dev Biol; 2022; 10():1001954. PubMed ID: 36568979
    [No Abstract]   [Full Text] [Related]  

  • 5. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
    Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
    BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
    Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
    World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of a prognostic model based on 11 lymph node metastasis-related genes for overall survival in endometrial cancer.
    Wu H; Feng H; Miao X; Ma J; Liu C; Zhang L; Yang L
    Cancer Med; 2022 Dec; 11(23):4641-4655. PubMed ID: 35778922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating the role of FADS family members in breast cancer based on bioinformatic analysis and experimental validation.
    Zhao T; Gao P; Li Y; Tian H; Ma D; Sun N; Chen C; Zhang Y; Qi X
    Front Immunol; 2023; 14():1074242. PubMed ID: 37122728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the risk of lymph node metastasis and the expression of GBP1 in breast cancer patients.
    Liu Y; Wu Z; Lin J; Wang Z
    Pak J Med Sci; 2024; 40(1Part-I):159-164. PubMed ID: 38196488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of Lymph Node Metastasis-Related Prognostic Model and Analysis of Immune Infiltration Mode in Lung Adenocarcinoma.
    Li W; Ou D; Zhang J; Ye M
    Comput Math Methods Med; 2022; 2022():3887857. PubMed ID: 35836921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and Evaluation of a Risk Score Model for Lymph Node Metastasis-Associated Circadian Clock Genes in Esophageal Squamous Carcinoma.
    Cheng J; Chen F; Cheng Y
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel cuproptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of breast cancer patients.
    Jiang ZR; Yang LH; Jin LZ; Yi LM; Bing PP; Zhou J; Yang JS
    Front Oncol; 2022; 12():988680. PubMed ID: 36203428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of risk factors for lymph node metastasis and prognosis study in patients with early gastric cancer: A SEER data-based study.
    Li J; Cui T; Huang Z; Mu Y; Yao Y; Xu W; Chen K; Liu H; Wang W; Chen X
    Front Oncol; 2023; 13():1062142. PubMed ID: 37007147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a machine learning model to predict the risk of lymph node metastasis in renal carcinoma.
    Feng X; Hong T; Liu W; Xu C; Li W; Yang B; Song Y; Li T; Li W; Zhou H; Yin C
    Front Endocrinol (Lausanne); 2022; 13():1054358. PubMed ID: 36465636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A nomogram for predicting lymph node metastasis in early gastric cancer].
    Cui H; Cao B; Deng H; Liu GB; Liang WQ; Xie TY; Ye L; Zhang QP; Wang N; Liu FD; Wei B
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jan; 25(1):40-47. PubMed ID: 35067033
    [No Abstract]   [Full Text] [Related]  

  • 17. Unfolded protein response signature unveils novel insights into breast cancer prognosis and tumor microenvironment.
    Zhou N; Kong D; Lin Q; Yang X; Zhou D; Lou L; Huang F
    Cancer Genet; 2023 Aug; 276-277():17-29. PubMed ID: 37343507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Combined four-mRNA Signature Associated with Lymphatic Metastasis for Prognosis of Colorectal Cancer.
    Li X; Zhang Q; Zhao L; Jiang L; Qi A; Wei Q; Song X; Wang L; Zhang L; Zhao Y; Lv X; Wei M; Zhao L
    J Cancer; 2020; 11(8):2139-2149. PubMed ID: 32127941
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification and development of an independent immune-related genes prognostic model for breast cancer.
    Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
    BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.
    Lu M; Zhan H; Liu B; Li D; Li W; Chen X; Zhou X
    EPMA J; 2021 Dec; 12(4):589-604. PubMed ID: 34950253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.